Genome-wide association studies (GWAS) reveal that variants in BMAL1 are associated with insulin resistance (20, 21), cardiovascular health (21, 22), prostate cancer (23), lung cancer (24), chronotype (25), sociability (26), and neurodegeneration (27). Here, BMAL1 is linked to Familial prostate cancer.